PureHealth Reports Net Profit of USD 337 Million in H1 2026
PureHealth Reports Net Profit of USD 337 Million in H1 2026 |
| [31-July-2026] |
ABU DHABI, UAE, July 31, 2026 /PRNewswire/ -- PureHealth Holding PJSC ("PureHealth" or "the Group") (ADX Symbol: PUREHEALTH), the largest healthcare group in the Middle East, today announced its financial results for the six-month period ended 30 June 2026. The Group delivered a strong financial and operational performance during the first half of the year, primarily supported by continued momentum across its international Care (healthcare) platform and resilient growth in the Cover (insurance) vertical.
Group revenue increased 9% year-on-year to USD 4.0 billion, driven by continued expansion of PureHealth's international Care portfolio following the integration of Hellenic Healthcare Group (HHG) in Greece and Cyprus, alongside sustained growth in the Cover vertical in H1 2026. EBITDA increased 24% year-on-year to USD 782 million, reflecting the increasing contribution from higher-margin international operations and ongoing operational transformation across the Group in H1 2026. Net profit increased 20% year-on-year to USD 337 million in the same period. H.E. Kamal Al Maazmi, Chairman of PureHealth, said: "PureHealth's performance in the first half of 2026 reflects the strength of our long-term strategy and the disciplined execution of our vision to build a globally diversified healthcare group with a resilient portfolio and a strong financial foundation. As our international operations continue to expand alongside our established leadership in the UAE, we remain focused on strengthening the resilience of our business, diversifying our earnings base, and reinforcing the foundations for sustainable long-term growth. We will continue to maintain disciplined capital allocation, directing investments towards opportunities that advance our strategic priorities and enhance our ability to create sustainable value for our shareholders and the communities we serve." Shaista Asif, Group Chief Executive Officer of PureHealth, commented: "The first half of the year demonstrated the strength and resilience of our integrated platform model, delivering profitable growth across our business. Our international portfolio continued to scale, insurance maintained strong momentum, and patient activity across our UAE network grew in the second quarter. At the same time, we continued to invest in advanced clinical capabilities, digital front door of PURA, AI-enabled technologies and capacity expansion across our ecosystem. These investments are strengthening the quality of services we provide today while positioning PureHealth for its next phase of growth." Financial & Operational Highlights Across the Care and Cover Verticals International (Care): Revenue increased 56% year-on-year to USD 1.3 billion in H1 2026, primarily reflecting the consolidation of HHG alongside continued underlying growth across Circle Health. EBITDA increased 65% year-on-year to USD 300 million in H1 2026, with EBITDA margin expanding to 22.2%, highlighting the margin-accretive nature of the Group's international portfolio. Circle Health in the UK continued to deliver solid underlying performance, with revenue increasing 6.3% year-on-year, supported by a greater proportion of higher-acuity and more complex inpatient procedures. HHG maintained strong momentum across Greece and Cyprus, with patient volumes increasing 6% year-on-year, driven primarily by outpatient growth in H1 2026. International operations accounted for 33% of Group revenue during H1 2026, strengthening PureHealth's geographic diversification and earnings resilience. UAE (Care): Revenue registered USD 1.6 billion in H1 2026. Patient activity strengthened through the second quarter, supported by heightened patient activity across the network. Outpatient volumes increased 7% year-on-year and inpatient volumes increased 10%, while bed occupancy across UAE hospitals increased to 75% in H1 2026. EBITDA increased 7% year-on-year to USD 332 million, reflecting improved underlying operational performance, stronger patient activity and continued cost discipline across the business in H1 2026. Insurance (Cover): Revenue increased 10% year-on-year to USD 1.1 billion. Gross Written Premium increased 13% year-on-year to USD 1.5 billion, supported by strong renewals, disciplined underwriting, and continued new business growth in H1 2026. The number of insured members increased 4% year-on-year to 3.4 million, while Daman's Property & Casualty business continued to build momentum, generating approximately USD 22 million in Gross Written Premium during H1 2026 as all product lines gained market traction. In June, Daman was assigned an A1 Insurance Financial Strength Rating (IFSR) by Moody's Ratings with a stable outlook. The A1 rating, the highest IFSR assigned by Moody's to a UAE insurer, reinforces Daman's financial strength, market leadership, and resilient business model. Key Strategic Updates
Outlook Following a strong first half of 2026, PureHealth remains confident in its medium-term growth trajectory and is reaffirming its strategic and financial targets. The Group continues to benefit from an increasingly diversified earnings base, with its international healthcare platform, expanding insurance business, and resilient UAE operations providing multiple drivers of sustainable growth. Looking ahead, PureHealth expects continued momentum across its international portfolio as recent acquisitions mature, operational synergies deepen, and investments in specialised clinical capabilities continue to enhance returns. In the UAE, the Group expects underlying activity to remain healthy, supported by growing demand, expanded capacity, and an increasing focus on higher-acuity services. At the same time, Daman will continue scaling its Property & Casualty business while maintaining underwriting discipline and strengthening its multi-line insurance platform.
SOURCE PureHealth | ||
Company Codes: AbuDhabi:PUREHEALTH,ADX:PUREHEALTH |
View original content to download multimedia:
